Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Symposium on Signalling Pathways in Cancer 2016: Focusing on the HER/EGFR family signalling

Start date: 04 Mar 2016
End date: 05 Mar 2016
Location: Sitges, Barcelona, Spain

The 4^th Symposium ‘Focusing on HER/EGFR family signalling’ was held in partnership with EACR. This Symposium is designed for medical oncologists, clinical and industry researchers and young oncologists.

The objective of the annual ESMO Symposium on Signalling Pathways in Cancer is to bring together academics, clinical researchers and industry researchers who are actively working in specific tumour settings in order to facilitate knowledge sharing through a series of interactive sessions and workshops.

Organised in Partnership with:

Committee Co-Chairs

Josep Tabernero, Barcelona, Spain (ESMO) and Clare Isacke, London, UK (EACR)

ESMO Symposium on Signalling Pathways in Cancer 2016: Focusing on the HER/EGFR family signalling

Committee Co-Chairs

Programme

Industry Participation

Symposium Officers